Matching trials
2,411 results
- Impact of Oxytocin on Obstructive Sleep Apnea Induced Changes in Sleep: Complete Statistical AnalysisIndependent statistical analysis of Impact of Oxytocin on Obstructive Sleep Apnea Induced Changes in Sleep: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- IMPACT-TBIndependent statistical analysis of A Clinical Trial of the Safety, Pharmacokinetics and Hematologic Effects of Imatinib on Myelopoiesis in Adults When Given With and Without Isoniazid and Rifabutin: primary endpoint results, effect…
- IMPALAIndependent statistical analysis of Efficacy and Safety of Inhaled Molgramostim (rhGM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Imprime PGG, Alemtuzumab, and Rituximab in Treating Patients With High Risk Chronic Lymphocytic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Imprime PGG, Alemtuzumab, and Rituximab in Treating Patients With High Risk Chronic Lymphocytic Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Improving Cognitive Health in COVID-19 Survivors: Complete Statistical AnalysisIndependent statistical analysis of Improving Cognitive Health in COVID-19 Survivors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04843930).
- Improving Obstructive Sleep Apnea Management Via Wireless Telemonitoring: Complete Statistical AnalysisIndependent statistical analysis of Improving Obstructive Sleep Apnea Management Via Wireless Telemonitoring: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00682838).
- Improving SCI Rehabilitation Interventions by Retraining the Brain: Complete Statistical AnalysisIndependent statistical analysis of Improving SCI Rehabilitation Interventions by Retraining the Brain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03892746).
- Improving Treatment Adherence in HIV-Infected Individuals: Complete Statistical AnalysisIndependent statistical analysis of Improving Treatment Adherence in HIV-Infected Individuals: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00247611).
- IN Insulin in Type 1 Diabetes (T1D) Hypoglycemia Unawareness: Safety Only Phase: Complete Statistical AnalysisIndependent statistical analysis of IN Insulin in Type 1 Diabetes (T1D) Hypoglycemia Unawareness: Safety Only Phase: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- INCB001158 Combined With Subcutaneous (SC) Daratumumab, Compared to Daratumumab SC, in Relapsed or Refractory Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of INCB001158 Combined With Subcutaneous (SC) Daratumumab, Compared to Daratumumab SC, in Relapsed or Refractory Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer: Complete Statistical AnalysisIndependent statistical analysis of Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03416153).
- Individualized Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery: Complete Statistical AnalysisIndependent statistical analysis of Individualized Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Inflammation and Coronary Endothelial Function: Complete Statistical AnalysisIndependent statistical analysis of Inflammation and Coronary Endothelial Function: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02366091).
- Inflammation and Vascular Function in Atherosclerosis: Complete Statistical AnalysisIndependent statistical analysis of Inflammation and Vascular Function in Atherosclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00760019).
- Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis: Complete Statistical AnalysisIndependent statistical analysis of Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Influence of Ribavirin on the Initial Virological Response in Treatment Naïve Patients With Hepatitis C Genotype 1 Infection: Complete Statistical AnalysisIndependent statistical analysis of Influence of Ribavirin on the Initial Virological Response in Treatment Naïve Patients With Hepatitis C Genotype 1 Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Influenza Vaccine in Pregnant Women: Complete Statistical AnalysisIndependent statistical analysis of Influenza Vaccine in Pregnant Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00905125).
- Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes: Complete Statistical AnalysisIndependent statistical analysis of Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes: primary endpoint results,…
- Inhaled Nitric Oxide for Pulmonary Hypertension and Bronchopulmonary Dysplasia: Complete Statistical AnalysisIndependent statistical analysis of Inhaled Nitric Oxide for Pulmonary Hypertension and Bronchopulmonary Dysplasia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03576885).
- INOVAOPIOIDIndependent statistical analysis of Effectiveness of an Opioid Sparing Pain Regimen in Cardiac Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03679013).
- INROADSIndependent statistical analysis of A Study of the Once Daily Combination of Etravirine and Darunavir/Ritonavir As Dual Therapy in Early Treatment-Experienced Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- INS-2Independent statistical analysis of Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- INSIGHTIndependent statistical analysis of A Study to Assess Intrahepatic and Peripheral Changes of Immunologic and Virologic Markers in Chronic Hepatitis B Virus Infection: primary endpoint results, effect estimate with confidence interval, sample-size…
- INSIGHTIndependent statistical analysis of Extension Study to Study PQ-110-001 (NCT03140969): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03913130).
- INSIGHT 2An independent statistical analysis of INSIGHT 2 (NCT03940703), a phase 2 study of tepotinib plus osimertinib in osimertinib-relapsed MET-amplified non-small cell lung cancer.
- InterAACTIndependent statistical analysis of the InterAACT phase 2 randomized trial comparing cisplatin plus 5-FU with carboplatin plus weekly paclitaxel in advanced anal squamous cell carcinoma.
- Investigate Safety, Pharmacokinetics and Pharmacodynamics of GSK2118436 & GSK1120212: Complete Statistical AnalysisIndependent statistical analysis of Investigate Safety, Pharmacokinetics and Pharmacodynamics of GSK2118436 & GSK1120212: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01072175).
- Investigation of a Long-Acting Follicle Stimulating Hormone in Infertile Women Undergoing Assisted Reproductive Technology (ART): Complete Statistical AnalysisIndependent statistical analysis of Investigation of a Long-Acting Follicle Stimulating Hormone in Infertile Women Undergoing Assisted Reproductive Technology (ART): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Investigation of a New Trial Drug (FE200486) in Prostate Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Investigation of a New Trial Drug (FE200486) in Prostate Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Investigation of Efficacy and Safety of Botulinum Toxin A (Botox-Allergan Inc) in Migraine Headaches: Complete Statistical AnalysisIndependent statistical analysis of Investigation of Efficacy and Safety of Botulinum Toxin A (Botox-Allergan Inc) in Migraine Headaches: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Investigation of Efficacy and Safety of Three Dose Levels of Subcutaneous Semaglutide Once Daily Versus Placebo in Subjects With Non-alcoholic Steatohepatitis.: Complete Statistical AnalysisIndependent statistical analysis of Investigation of Efficacy and Safety of Three Dose Levels of Subcutaneous Semaglutide Once Daily Versus Placebo in Subjects With Non-alcoholic Steatohepatitis.: primary endpoint results, effect estimate with confidence…
- Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Investigation of Mifepristone (RU486) on Stress Sensitivity and Relapse Prevention in Cocaine Dependent Patients: Complete Statistical AnalysisIndependent statistical analysis of Investigation of Mifepristone (RU486) on Stress Sensitivity and Relapse Prevention in Cocaine Dependent Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Investigation of the 24 Hour Forced Expiratory Flow in 1 Second (FEV1) Profile of a Single Dose of Indacaterol/Mometasone Delivered Via the TWISTHALER® Device in Adult Patients With Persistent Asthma: Complete Statistical AnalysisIndependent statistical analysis of Investigation of the 24 Hour Forced Expiratory Flow in 1 Second (FEV1) Profile of a Single Dose of Indacaterol/Mometasone Delivered Via the TWISTHALER® Device in Adult Patients With…
- ION-ASDIndependent statistical analysis of Oxytocin and Social Cognitive Skills Groups: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02918864).
- IPCIndependent statistical analysis of Feasibility of an Integrated Patient Care (IPC) System Using Daily Filling Pressures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- IPF-201Independent statistical analysis of Phase 2a Evaluation of PLN-74809 on αvβ6 Receptor Occupancy Using PET Imaging in Participants With IPF/: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Irinotecan and Carboplatin in Treating Patients With Metastatic or Recurrent Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Irinotecan and Carboplatin in Treating Patients With Metastatic or Recurrent Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery: Complete Statistical AnalysisIndependent statistical analysis of Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery: primary endpoint results,…
- Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal Junction: Complete Statistical AnalysisIndependent statistical analysis of Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal Junction: primary endpoint results, effect estimate with confidence interval,…
- Irofulven in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Irofulven in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Iron Sucrose in Non-Dialysis Dependent (NDD-CKD) Pediatric Patients: Complete Statistical AnalysisIndependent statistical analysis of Iron Sucrose in Non-Dialysis Dependent (NDD-CKD) Pediatric Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00721188).
- Islet Transplantation for Type 1 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Islet Transplantation for Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00014911).
- Itacitinib + Everolimus in Hodgkin Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Itacitinib + Everolimus in Hodgkin Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03697408).
- Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelofibrosis Undergoing Reduced Intensity Conditioning Donor Stem Cell Transplantation: Complete Statistical AnalysisIndependent statistical analysis of Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelofibrosis Undergoing Reduced Intensity Conditioning Donor Stem Cell Transplantation: primary endpoint…
- IV or IV/PO Omadacycline vs. IV/PO Levofloxacin for the Treatment of Acute Pyelonephritis: Complete Statistical AnalysisIndependent statistical analysis of IV or IV/PO Omadacycline vs. IV/PO Levofloxacin for the Treatment of Acute Pyelonephritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- IVIg for Small Fiber Neuropathy With Autoantibodies TS-HDS and FGFR3: Complete Statistical AnalysisIndependent statistical analysis of IVIg for Small Fiber Neuropathy With Autoantibodies TS-HDS and FGFR3: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03401073).
- Ixazomib Citrate in Treating Patients With Relapsed Multiple Myeloma That Is Not Refractory to Bortezomib: Complete Statistical AnalysisIndependent statistical analysis of Ixazomib Citrate in Treating Patients With Relapsed Multiple Myeloma That Is Not Refractory to Bortezomib: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- IXTENDIndependent statistical analysis of Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Janus Kinase Inhibition in Granuloma Annulare: Complete Statistical AnalysisIndependent statistical analysis of Janus Kinase Inhibition in Granuloma Annulare: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05650736).